Discontinued — last reported Q4 '25
Apollo Global Management Acquisitions remained flat by 0.0% to -$24.75M in Q4 2025 compared to the prior quarter.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $0.00 | $0.00 | -$99.00M |